BBH ETF

$190.04
Screen 3,400+ ETFsFind similar ETFs with lower fees
Showing top 20 of 27 holdings— Unlock all holdings(as of Dec 31, 2025)
#Ticker ↕Name ↕Weight ↓Shares ↕Mkt Value ↕Share ChgSectorIndustry
1AMGNAmgen Inc.15.09%173,268$56.71M••••••••••••••••••••••
2GILDGilead Sciences Inc14.38%440,313$54.04M••••••••••••••••••••••
3VRTXNvaesrtex Pharmaceuticals Inc9.12%75,637$34.29M••••••••••••••••••••••
4REGNRegeneron Pharmaceuticals, Inc.7.73%37,632$29.05M••••••••••••••••••••••
5ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs4.72%21,100$17.74M••••••••••••••••••••••
6IQVI Q V I A Holdings Inc.4.55%75,827$17.09M••••••••••••••••••••••
7ALNYAlnylam Pharmace4.42%41,792$16.62M••••••••••••••••••••••
8NTRANatera Inc4.28%70,207$16.08M••••••••••••••••••••••
9INSMInsmed Inc4.12%89,035$15.50M••••••••••••••••••••••
106160:SMBeone Medicines Ltd3.17%39,208$11.91M••••••••••••••••••••••
11BIIBBiogen Inc. Com3.16%67,436$11.87M••••••••••••••••••••••
12UTHRUnited Therapeutics Corp2.97%22,934$11.17M••••••••••••••••••••••
13ILMNIllumina, Inc.2.61%74,698$9.80M••••••••••••••••••••••
14ICLRIcon Eur0.062.46%50,701$9.24M••••••••••••••••••••••
15EXASExact Sciences Corp.2.20%81,566$8.28M••••••••••••••••••••••
16INCYIncyte Corp1.96%74,488$7.36M••••••••••••••••••••••
17NBIXNeurocrine Bioscienc1.95%51,653$7.33M••••••••••••••••••••••
18BNTX:FFBiontech Se Adr1.82%71,934$6.85M••••••••••••••••••••••
19MRNAModerna therapeutics1.59%202,391$5.97M••••••••••••••••••••••
20CRLCharles River Laboratories International Inc1.39%26,214$5.23M••••••••••••••••••••••
7+ more holdings available
See all 27 holdings with sector, industry, share changes & CSV export
Unlock All Holdings — $149 $60/mo
Limited to first 500 subscribers - Cancel anytime

BBH ETF All Holdings

BBH holdings total 27 positions. The top 10 holdings account for 71.6% of the fund, led by Amgen Inc. at 15.1%, Gilead Sciences Inc at 14.4%, Nvaesrtex Pharmaceuticals Inc at 9.1%.

BBH portfolio concentration is relatively high, with the top 10 representing 71.6% of total assets. The largest sector exposure is Health Care at 92.4%.

BBH sector allocation provides a detailed breakdown. BBH overlap tool shows how holdings compare to other funds in your portfolio.

BBH ETF Holdings

27 of 27 holdings

  • 1

    Amgen Inc.

    AMGNHealth Care
    15.09%
  • 2

    Gilead Sciences Inc

    GILDHealth Care
    14.38%
  • 3

    Nvaesrtex Pharmaceuticals Inc

    VRTXHealth Care
    9.12%
  • 4

    Regeneron Pharmaceuticals, Inc.

    REGNHealth Care
    7.73%
  • 5

    Argenx Se Spon Adr Each Rep 1 Ord Shs

    ARGX:ASHealth Care
    4.72%
  • 6

    I Q V I A Holdings Inc.

    IQVHealth Care
    4.55%
  • 7

    Alnylam Pharmace

    ALNYHealth Care
    4.42%
  • 8

    Natera Inc

    NTRAHealth Care
    4.28%
  • 9

    Insmed Inc

    INSMHealth Care
    4.12%
  • 10

    Beone Medicines Ltd

    6160:SMUnknown
    3.17%
  • 11

    Biogen Inc. Com

    BIIBHealth Care
    3.16%
  • 12

    United Therapeutics Corp

    UTHRHealth Care
    2.97%
  • 13

    Illumina, Inc.

    ILMNHealth Care
    2.61%
  • 14

    Icon Eur0.06

    ICLRHealth Care
    2.46%
  • 15

    Exact Sciences Corp.

    EXASHealth Care
    2.20%
  • 16

    Incyte Corp

    INCYUnknown
    1.96%
  • 17

    Neurocrine Bioscienc

    NBIXHealth Care
    1.95%
  • 18

    Biontech Se Adr

    BNTX:FFHealth Care
    1.82%
  • 19

    Moderna therapeutics

    MRNAHealth Care
    1.59%
  • 20

    Charles River Laboratories International Inc

    CRLHealth Care
    1.39%
  • 21

    Bio Techne

    TECHHealth Care
    1.32%
  • 22

    Repligen Corp

    RGENHealth Care
    1.31%
  • 23

    Qiagen Nv

    QGEN:ASUnknown
    1.27%
  • 24

    Biomarin Pharmaceutical Inc.

    BMRNHealth Care
    1.22%
  • 25

    Tempus Ai

    TEMInformation Technology
    1.09%
  • 26

    Wisconsin Public Service Corp. 2.85% 12/1/2051

    Other
    0.14%
  • 27

    Other/cash

    Other
    -0.05%